Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Entertainment Now
Spring Wellness
Home & Garden
Home Improvement
Home & Realty
Outdoor Guide
Women
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Services
Readersâ Choice
Auction
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Axsome Therapeutics, Inc.
Axsome Therapeutics to Present New Sunosi® Data at SLEEP 2023
June 01, 2023
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Tickers
AXSM
Axsome Therapeutics to Present Data and Post-Hoc Analyses on Auvelity® and Sunosi® at the 2023 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting
May 30, 2023
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Tickers
AXSM
Axsome Therapeutics Reports First Quarter 2023 Financial Results and Corporate Update
May 08, 2023
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Tickers
AXSM
Axsome Therapeutics to Present at the Bank of America Securities 2023 Healthcare Conference
May 03, 2023
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Tickers
AXSM
Axsome Therapeutics Joins Mental Health America and the State of New York to Raise Awareness of Mental Health During May is Mental Health Month
May 01, 2023
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Tickers
AXSM
Axsome Therapeutics to Present Five Abstracts Including New Data from the Positive SHARP Study of SUNOSI® (solriamfetol) in Participants with Cognitive Impairment with Excessive Daytime Sleepiness in Obstructive Sleep Apnea at the 2023 American Academy of
April 21, 2023
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Tickers
AXSM
Axsome Therapeutics to Present at the 22nd Annual Needham Virtual Healthcare Conference
April 14, 2023
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Tickers
AXSM
Axsome Therapeutics to Report First Quarter 2023 Financial Results on May 8
April 13, 2023
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Tickers
AXSM
Axsome Therapeutics to Present at Cowen’s 43rd Annual Health Care Conference
March 01, 2023
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Tickers
AXSM
Axsome Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
February 27, 2023
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Tickers
AXSM
Axsome Therapeutics Enters into License Agreement with Pharmanovia to Expand Commercialization and Further Develop Sunosi® (solriamfetol) in Europe
February 22, 2023
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Tickers
AXSM
Axsome Therapeutics to Present at the SVB Securities Global Biopharma Conference
February 07, 2023
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Tickers
AXSM
Axsome Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on February 27
January 31, 2023
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Tickers
AXSM
Axsome Therapeutics Presents New Data from the EVOLVE Open-Label Trial Demonstrating Effects of AUVELITY® on Cognitive and Physical Functioning in Patients with Major Depressive Disorder at the American College of Neuropsychopharmacology (ACNP) 2022
December 07, 2022
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Tickers
AXSM
Axsome Therapeutics Announces AXS-05 Achieves Primary Endpoint in the ACCORD Phase 3 Trial in Alzheimer’s Disease Agitation
November 28, 2022
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Tickers
AXSM
Axsome Therapeutics to Present at the 5th Annual Evercore ISI HealthCONx Conference
November 23, 2022
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Tickers
AXSM
Axsome Therapeutics to Present at the Guggenheim 4th Annual Immunology and Neurology Conference
November 09, 2022
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Tickers
AXSM
Axsome Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
November 07, 2022
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Tickers
AXSM
Axsome Therapeutics to Ring the NASDAQ Stock Market Opening Bell Today
October 27, 2022
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Tickers
AXSM
Axsome Therapeutics to Report Third Quarter 2022 Financial Results on November 7, 2022
October 21, 2022
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Tickers
AXSM
Axsome Therapeutics Announces Availability of AUVELITY™, the First and Only Oral NMDA Receptor Antagonist for the Treatment of Major Depressive Disorder in Adults
October 20, 2022
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Tickers
AXSM
Axsome Therapeutics Voices its Commitment to Mental Health on World Mental Health Day 2022
October 10, 2022
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Tickers
AXSM
Axsome Therapeutics Announces Sunosi® (Solriamfetol) Meets Primary Endpoint Demonstrating Improvement in Cognitive Function in the SHARP Trial in Cognitively Impaired Patients with Excessive Daytime Sleepiness Associated with Obstructive Sleep Apnea
October 03, 2022
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Tickers
AXSM
Axsome Therapeutics Announces Plans to Resubmit AXS-07 NDA Based on Successful FDA Type A Meeting
September 29, 2022
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Tickers
AXSM
Axsome Therapeutics to Report Second Quarter 2022 Financial Results on August 9, 2022
July 28, 2022
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Tickers
AXSM
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.